LOGO B133 (Catapres-TTS-3 0.3 mg / 24 hour)
Pill imprint LOGO B133 has been identified as Catapres-TTS-3 0.3 mg / 24 hour.
Clonidine is used in the treatment of opiate withdrawal; adhd; anxiety; bipolar disorder; benzodiazepine withdrawal (and more), and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Clonidine 0.3 mg / 24 hour is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- LOGO B133
- Strength:
- 0.3 mg / 24 hour
- Color:
- Pink
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Boehringer Ingelheim Pharmaceuticals, Inc.
More about clonidine
Consumer resources
- Clonidine extended-release tablets
- Clonidine patches
- Clonidine suspension
- Clonidine tablets
- Clonidine transdermal
- More (3) »
- Other brands: Catapres, Catapres-TTS, Kapvay, Jenloga, More (2) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
